Prostate cancer Doctors in Turkey — Page 3

Uzm. Dr. Erkan Göcen is a Radiation Oncology Specialist at Çerkezköy Private Optimed Hospital (Optimed Health Group). He graduated from İstanbul University, İstanbul Faculty of Medicine (Çapa) in 2003.

Career: He trained and practiced in Radiation Oncology from 2010 to 2012. He worked in public and private health institutions from 2012 to 2016. He served in the private medical sector as a Radiation Oncology Specialist from 2016 to 2023. He has been at Optimed Hospital since 2024.

Clinical interests: cancers of the brain, head and neck, esophagus, stomach, colorectal, pancreas, prostate, bladder, lung, soft tissues (sarcomas), skin, uterus and cervix, and breast. Affiliations: Turkish Society for Radiation Oncology (TROD) and Tekirdağ Medical Chamber. Languages: English and Turkish.

Dr. Zulfu Sertkaya is an associate professor and andrologist at Andro Expertise in Istanbul. He holds the FEBU title from the European Association of Urology. Dr. Sertkaya focuses on male health, sexual function, and aesthetic urological procedures. He treats patients at his clinic and performs surgeries at affiliated hospitals.

• Earned Fellow of the European Board of Urology (FEBU) status.
• Specialize in andrology, male sexual health, and aesthetic urology.
• Performs penile implant surgery and varicocelectomy for infertility.
• Works at a clinic accredited by the Turkish Medical Association.

Dr. Tuncay Tas is a urological surgeon at Safe Urology Clinic in Istanbul. He is among the first five experts globally to publish data on P-Shot applications. Dr. Tas specializes in urological oncology and male sexual health. He completed a fellowship in laparoscopic urology at Heidelberg University, Germany.

• Pioneered combined PRP and stem cell penile therapy in Turkey.
• Developed a certified surgical technique for penile circumference improvement.
• Performs robotic prostatectomies and kidney-sparing surgeries for cancer treatment.
• Serves as an instructor for the International Society for Stem Cells Applications.

Professor Elnur Sahibov is a specialist in radiation oncology at Emsey Hospital, having trained at the prestigious Marmara University Faculty of Medicine.

• Specialises in precise radiation therapy for managing prostate cancer cases
• Completed oncology specialisation at Marmara University Department of Radiation Oncology
• Delivers treatment in English, ensuring clear communication for international patients
• Focuses on targeted radiation to minimise damage to healthy tissue

Dr. Ayşe İrem Yasin is a medical oncologist at Medipol Acıbadem District Hospital in Istanbul. She holds a prestigious ESMO Board Certificate. Dr. Yasin specializes in solid tumors, including breast, lung, and gastrointestinal cancers. She treats complex cases such as Merkel cell carcinoma and cancers of unknown primary.

• Trained at Harvard Medical School, Cleveland Clinic, and Basel University Hospital.
• Completed a clinical observership at the Breast Cancer Unit in Novara, Italy.
• Treats brain and CNS malignancies, soft tissue sarcomas, and urologic cancers.
• Works at a JCI-accredited facility equipped with the da Vinci robotic system.

Associate Professor Nail Paksoy is an ESMO-certified medical oncologist specialising in systemic treatments for advanced prostate cancer at Medipol Bahçelievler University Hospital.

• Expert in PSMA-based imaging to assess tumour burden and guide targeted treatment for prostate cancer
• Uses PRRT therapy – a targeted radiation treatment that destroys cancer cells with minimal impact on healthy tissue
• Board-certified by the European Society for Medical Oncology (ESMO) in medical oncology
• Subinvestigator for major international clinical trials developing the latest cancer drug protocols

Professor Senem Karabulut is a leading medical oncologist at Biruni University Hospital with a PhD in molecular oncology – the study of cancer at a genetic level.

• Specialises in genitourinary cancers, including advanced prostate cancer cases
• Uses immunotherapies and targeted treatments to attack cancer cells precisely
• Recognised by the European Society for Medical Oncology (ESMO) board
• Qualified in phytotherapy to support traditional cancer care with plant-based medicine
• Ranked 14th in Turkey's prestigious national medical subspecialty examination

Associate Professor Turkan Ozturk Topcu is a highly qualified medical oncologist at Biruni University Hospital with international training from world-leading cancer centres.

• Completed a fellowship at the MD Anderson Cancer Center in the USA
• Trained at the Sunnybrook Odette Cancer Center Breast Cancer Clinic in Canada
• Holds professional membership with the American Society of Medical Oncology (ASCO)
• Full member of the European Society for Medical Oncology (ESMO)
• Specialises in medical oncology for various urological and solid tumours

Dr. Atakan Topcu is a medical oncologist at Medipol Acibadem District Hospital in Istanbul. He specializes in treating solid tumors including lung, breast, and colorectal cancers. Dr. Topcu is an Associate Professor with over 50 peer-reviewed scientific publications. He sits on the Editorial Board of the medical journal BMC Cancer.

• Expertise in immunotherapy, targeted therapies, and geriatric oncology care.
• Treats cancer-related malnutrition, cachexia, and sarcopenia.
• Maintains active membership in the European Society for Medical Oncology (ESMO).
• Works at a JCI-accredited hospital specializing in advanced oncology treatments.

Professor Gul Alco is a leading radiation oncologist at Medipol Acibadem District Hospital, specialising in precisely targeted therapy for prostate cancer.

• Holds a professorship at Istanbul Medipol University, training the next generation of cancer specialists
• Uses intensity-modulated radiation therapy (IMRT) to deliver high-dose radiation while protecting healthy surrounding tissue
• Focuses on curative radiotherapeutic approaches for both localised and advanced-stage prostate tumours
• Member of the Turkish Society for Radiation Oncology and diverse international medical organisations

Professor Selami Albayrak is a senior urology specialist at Medipol Mega University Hospital, where he leads the department in managing complex prostate cases.

• Specialises in uro-oncology with a focus on malignant prostate conditions
• Expert in robotic-assisted surgery for precise tumour removal and nerve preservation
• Performs minimally invasive procedures to reduce recovery time and post-operative pain
• Member of the Turkish Association of Urology and the European Association of Urology
• Part of a multidisciplinary team at a major university teaching hospital

Prof. Dr. Gül Alço is a radiation oncologist with about 27 years of experience. She treats breast, lung, prostate, gastrointestinal, gynecologic, central nervous system, head and neck, soft tissue, and bone cancers with radiotherapy.

Her expertise includes adaptive radiotherapy and radiosurgery. She uses advanced radiation techniques to provide personalized, evidence-based care in a multidisciplinary, patient-centered setting.

Prof. Dr. Ali Aydın Yavuz is a radiation oncology professor. He graduated from Hacettepe University Faculty of Medicine in 1989. He completed his specialty training in radiation oncology in 1996. He led the Department of Radiation Oncology at Karadeniz Technical University from 1997 to 2006. He served as an associate professor at Karadeniz Technical University and Başkent University from 2004 to 2009. He was Head of Radiation Oncology at Başkent University. He also served as Chief Physician of Başkent University Adana Kışla Campus for three years. He became a professor at Akdeniz University Faculty of Medicine in 2009 and remained on the faculty until 2018.

Internationally, he delivered Turkey’s first oral presentations at ASCO in 1999 and at ASTRO in 2000. In 2008 he gained experience at MD Anderson Cancer Center. He has authored many international publications. He now practices at Koru Ankara Hospital. His clinical focus includes lung, head and neck, brain, breast, gastrointestinal, urologic, gynecologic, skin, and soft tissue tumors.